<DOC>
	<DOCNO>NCT01698983</DOCNO>
	<brief_summary>Gluococorticoids commonly prescribe treat number disease include majority inflammatory disease . Despite considerable inter-personal variability response glucocorticoids asthmatic , insensitivity rate 30 % risk adverse side effect glucocorticoid therapy , assay currently perform determine sensitivity severe non-severe asthmatic prior treatment . The purpose study perform whole blood ex vivo stimulation assay interrogate know glucocorticoid receptor ( GR ) up- down-regulated gene indicate glucocorticoid sensitivity compare result severe non-severe asthmatic .</brief_summary>
	<brief_title>Ex Vivo Stimulation Whole Blood Means Determine Glucocorticoid Sensitivity Mild-to-Moderate Refractory Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Inclusion criterion : To eligible study , subject must meet following criterion : Age ≥ 18 year old Physician diagnosis asthma confirm medical record documentation . Documented history 12 % FEV1 reversibility postbronchodilator and/or Methacholine PC 20 score 16mg/ml less . Nonsmoker &gt; 6 month enrollment trial Less 5 pack year smoke history define average pack smoke per day multiply year active smoking . Willing able adhere study visit schedule protocolspecified procedure . Exclusion criterion : Subjects meet follow criterion may enrol study : Existence lung disease ( asthma ) Recent asthma exacerbation require hospital admission , unexpected healthcare visit , prednisone course previous 4 week . NonEnglish speaking . Participation another interventional research trial Selfreported pregnancy Inability unwillingness provide consent Febrile illness ( &gt; 38.0˚ C 100.4˚ F ) within 24 hour visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>